158 related articles for article (PubMed ID: 28002131)
1. Premedication Use Before Infliximab Administration: A Cross-sectional Analysis.
Picoraro J; Winberry G; Siegel CA; El-Matary W; Moses J; Grossman A; Park KT
Inflamm Bowel Dis; 2017 Jan; 23(1):174-180. PubMed ID: 28002131
[TBL] [Abstract][Full Text] [Related]
2. Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study.
Gold SL; Cohen-Mekelburg S; Schneider Y; Shen N; Faggen A; Rupert A; Scherl EJ; Bosworth B; Steinlauf A
Inflamm Bowel Dis; 2017 Oct; 23(10):1882-1889. PubMed ID: 28837521
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Rapid vs Standard Infliximab Infusions in the Pediatric Population.
Rozette NA; Hellauer CM; McKee C; Vazifedan T; Gabriel CA; Dice JE; Yokois NU
Inflamm Bowel Dis; 2018 Aug; 24(9):2007-2014. PubMed ID: 29788416
[TBL] [Abstract][Full Text] [Related]
4. Medical management of inflammatory bowel disease among Canadian gastroenterologists.
Jones J; Panaccione R; Russell ML; Hilsden R
Can J Gastroenterol; 2011 Oct; 25(10):565-9. PubMed ID: 22059162
[TBL] [Abstract][Full Text] [Related]
5. Variation in infliximab administration practices in the treatment of pediatric inflammatory bowel disease.
Adler J; Sandberg KC; Shpeen BH; Eder SJ; Dhanani M; Clark SJ; Freed GL
J Pediatr Gastroenterol Nutr; 2013 Jul; 57(1):35-8. PubMed ID: 23459317
[TBL] [Abstract][Full Text] [Related]
6. Variation in Care of Inflammatory Bowel Diseases Patients in Crohn's and Colitis Foundation of America Partners: Role of Gastroenterologist Practice Setting in Disease Outcomes and Quality Process Measures.
Weaver KN; Kappelman MD; Sandler RS; Martin CF; Chen W; Anton K; Long MD
Inflamm Bowel Dis; 2016 Nov; 22(11):2672-2677. PubMed ID: 27755268
[TBL] [Abstract][Full Text] [Related]
7. Premedication and infusion reactions with infliximab: results from a pediatric inflammatory bowel disease consortium.
Jacobstein DA; Markowitz JE; Kirschner BS; Ferry G; Cohen SA; Gold BD; Winter HS; Heyman MB; Baldassano RN
Inflamm Bowel Dis; 2005 May; 11(5):442-6. PubMed ID: 15867583
[TBL] [Abstract][Full Text] [Related]
8. Frequency of Severe Infusion Reactions Associated With Outpatient Infusion of Infliximab Without Premedications.
Hutsell SQ; Wu M; Park KT
J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):430-431. PubMed ID: 28937551
[TBL] [Abstract][Full Text] [Related]
9. Infliximab in inflammatory bowel disease. Is premedication necessary?
Nuñez F P; Quera R; Simian D; Flores L; Figueroa C; Ibañez P; Kronberg U; Lubascher J; Pizarro G
Gastroenterol Hepatol; 2021 May; 44(5):321-329. PubMed ID: 33386199
[TBL] [Abstract][Full Text] [Related]
10. Premedication as primary prophylaxis does not influence the risk of acute infliximab infusion reactions in immune-mediated inflammatory diseases: A systematic review and meta-analysis.
Fumery M; Tilmant M; Yzet C; Brazier F; Loreau J; Turpin J; Le Mouel JP; Goeb V; Nguyen-Khac E; Singh S; Dupas JL; Diouf M
Dig Liver Dis; 2019 Apr; 51(4):484-488. PubMed ID: 30686715
[TBL] [Abstract][Full Text] [Related]
11. Premedication with corticosteroids does not impact the pharmacokinetics of infliximab in inflammatory bowel disease irrespective of azathioprine cotreatment.
Larsen L; Jess T; Drewes AM; Dige A; Fallingborg J; Jacobsen BA; Aagaard B; Agnholt J
Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):964-967. PubMed ID: 31094854
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing acute infusion reactions in inflammatory bowel disease patients treated with infliximab in the era of scheduled maintenance therapy.
Duron C; Goutte M; Pereira B; Bommelaer G; Buisson A
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):705-11. PubMed ID: 25856689
[TBL] [Abstract][Full Text] [Related]
13. Infliximab therapy in children and adolescents with inflammatory bowel disease.
Veres G; Baldassano RN; Mamula P
Drugs; 2007; 67(12):1703-23. PubMed ID: 17683171
[TBL] [Abstract][Full Text] [Related]
14. Practice Variations in the Management of Inflammatory Bowel Disease Between Pediatric and Adult Gastroenterologists.
Assa A; Avni I; Ben-Bassat O; Niv Y; Shamir R
J Pediatr Gastroenterol Nutr; 2016 Mar; 62(3):372-7. PubMed ID: 26284542
[TBL] [Abstract][Full Text] [Related]
15. Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation.
Principi M; Losurdo G; La Fortezza RF; Lopolito P; Lovero R; Grillo S; Bringiotti R; Ierardi E; Di Leo A
J Gastrointestin Liver Dis; 2015 Jun; 24(2):165-70. PubMed ID: 26114175
[TBL] [Abstract][Full Text] [Related]
16. Gastroenterologists' prescribing of infliximab for Crohn's disease: a national survey.
St Charles M; Smith SR; Beardsley R; Fedder DO; Carter-Pokras O; Cross RK
Inflamm Bowel Dis; 2009 Oct; 15(10):1467-75. PubMed ID: 19266574
[TBL] [Abstract][Full Text] [Related]
17. Infliximab-induced skin manifestations in patients with inflammatory bowel disease.
Hellström AE; Färkkilä M; Kolho KL
Scand J Gastroenterol; 2016; 51(5):563-71. PubMed ID: 26728295
[TBL] [Abstract][Full Text] [Related]
18. Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients.
Alsaleh A; Gaidos JK; Kang L; Kuemmerle JF
Dig Dis Sci; 2016 Sep; 61(9):2602-7. PubMed ID: 27126205
[TBL] [Abstract][Full Text] [Related]
19. A nurse-led accelerated procedure for infliximab infusion is well tolerated and effective in patients with inflammatory bowel disease.
Michielan A; Martinato M; Favarin A; Zanotto V; Caccaro R; Caruso A; Sturniolo GC; D'Incà R
Dig Liver Dis; 2015 May; 47(5):372-7. PubMed ID: 25708258
[TBL] [Abstract][Full Text] [Related]
20. Rapid Infliximab Infusion in Children: A Multicenter Retrospective Cohort Study.
Lev-Tzion R; Assa A; Yerushalmi B; Lahad A; Friedman M; Ledder O; Turner D
J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):e101-e103. PubMed ID: 29064928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
